These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 21375212

  • 1. Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
    Manzoor NF, Azim S, Fadoo Z.
    J Pak Med Assoc; 2010 Nov; 60(11):977-9. PubMed ID: 21375212
    [Abstract] [Full Text] [Related]

  • 2. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group.
    N Engl J Med; 2002 Aug 08; 347(6):408-15. PubMed ID: 12167683
    [Abstract] [Full Text] [Related]

  • 3. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF, Boucher HW, Herbrecht R, Denning DW, Lortholary O, Ribaud P, Rubin RH, Wingard JR, DePauw B, Schlamm HT, Troke P, Bennett JE, European Organization for Research and Treatment of Cancer (EORTC) Invasive Fungal Infections Group (IFIG), Pfizer Global Aspergillus Study Group.
    Clin Infect Dis; 2005 Nov 15; 41(10):1448-52. PubMed ID: 16231256
    [Abstract] [Full Text] [Related]

  • 4. Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
    Meyer M, Waldvogel S, Chalandon Y, Bongiovanni M, Pache JC, Van Delden C.
    Scand J Infect Dis; 2007 Nov 15; 39(8):731-3. PubMed ID: 17654353
    [Abstract] [Full Text] [Related]

  • 5. Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.
    Azzola A, Passweg JR, Habicht JM, Bubendorf L, Tamm M, Gratwohl A, Eich G.
    J Clin Microbiol; 2004 Oct 15; 42(10):4805-8. PubMed ID: 15472346
    [Abstract] [Full Text] [Related]

  • 6. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
    Pagano L, Valentini CG, Fianchi L, Caira M.
    J Chemother; 2011 Feb 15; 23(1):5-8. PubMed ID: 21482486
    [Abstract] [Full Text] [Related]

  • 7. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Shehab N, DePestel DD, Mackler ER, Collins CD, Welch K, Erba HP.
    Pharmacotherapy; 2007 Jul 15; 27(7):970-9. PubMed ID: 17594202
    [Abstract] [Full Text] [Related]

  • 8. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    Sims-McCallum RP.
    Am J Health Syst Pharm; 2003 Nov 15; 60(22):2352-6. PubMed ID: 14652986
    [No Abstract] [Full Text] [Related]

  • 9. Voriconazole versus amphotericin B for invasive aspergillosis.
    Blot F, Edé C, Nitenberg GM.
    N Engl J Med; 2002 Dec 19; 347(25):2080-1; author reply 2080-1. PubMed ID: 12490695
    [No Abstract] [Full Text] [Related]

  • 10. Primary invasive oral aspergillosis: an updated literature review.
    Fuqua TH, Sittitavornwong S, Knoll M, Said-Al-Naief N.
    J Oral Maxillofac Surg; 2010 Oct 19; 68(10):2557-63. PubMed ID: 20417591
    [No Abstract] [Full Text] [Related]

  • 11. Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
    Powers JH, Dixon CA, Goldberger MJ.
    N Engl J Med; 2002 Jan 24; 346(4):289-90. PubMed ID: 11807157
    [No Abstract] [Full Text] [Related]

  • 12. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Mattei D, Mordini N, Lo Nigro C, Ghirardo D, Ferrua MT, Osenda M, Gallamini A, Bacigalupo A, Viscoli C.
    Bone Marrow Transplant; 2002 Dec 24; 30(12):967-70. PubMed ID: 12476292
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
    Hosokawa K, Yamazaki H, Mochizuki K, Ohata K, Ishiyama K, Hayashi T, Kondo Y, Sugimori N, Okumura H, Takami A, Nakao S.
    Transpl Infect Dis; 2012 Apr 24; 14(2):184-7. PubMed ID: 22093149
    [Abstract] [Full Text] [Related]

  • 14. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb 24; 13(69):13-6. PubMed ID: 15055210
    [Abstract] [Full Text] [Related]

  • 15. Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
    La Nasa G, Littera R, Maccioni A, Ledda A, Vacca A, Contu L.
    Hematol J; 2004 Feb 24; 5(2):178-80. PubMed ID: 15048069
    [Abstract] [Full Text] [Related]

  • 16. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    Ullmann AJ, Heussel CP, Cornely OA.
    N Engl J Med; 2002 May 30; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041526
    [No Abstract] [Full Text] [Related]

  • 17. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    Apisarnthanarak A, Little JR, Tebas P.
    N Engl J Med; 2002 May 30; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041527
    [No Abstract] [Full Text] [Related]

  • 18. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
    Slobbe L, Polinder S, Doorduijn JK, Lugtenburg PJ, el Barzouhi A, Steyerberg EW, Rijnders BJ.
    Clin Infect Dis; 2008 Dec 15; 47(12):1507-12. PubMed ID: 18990068
    [Abstract] [Full Text] [Related]

  • 19. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
    Santos RP, Sánchez PJ, Mejias A, Benjamin DK, Walsh TJ, Patel S, Jafri HS.
    Pediatr Infect Dis J; 2007 Apr 15; 26(4):364-6. PubMed ID: 17414408
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.